舒肝解郁胶囊联合氟西汀治疗抑郁症临床疗效及对心率变异性的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.4+1

基金项目:

丽水市科技计划项目(2017GYX27)


Clinical Effect of Shugan Jieyu Capsules Combined with Fluoxetine for Depression and Its Effect on Heart Rate Variability
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察舒肝解郁胶囊联合氟西汀治疗抑郁症临床疗效及对心率变异性(HRV) 的影响。方法:选择108 例抑郁症患者作为研究对象,按随机数字表法均分为2 组各54 例。对照组采取盐酸氟西汀胶囊治疗;研究组在对照组治疗方案的基础上联合舒肝解郁胶囊治疗。比较2 组汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、匹兹堡睡眠质量指数(PSQI)、HRV [正常窦性R-R 间期的标准差(SDNN)、低频率值(LF)、高频率值(HF)]、临床疗效及不良反应发生率。结果:治疗6 周后,2 组HAMD 及PSQI 显著低于治疗前,且研究组均低于对照组,差异均有统计学意义(P<0.05);治疗6 周后,2 组HAMA 均低于治疗前,差异均有统计学意义(P<0.05),但2 组间比较,差异无统计学意义(P>0.05)。治疗6 周后,研究组SDNN、HF 均显著高于治疗前,且均高于对照组,而LF 低于治疗前,且低于对照组,差异均有统计学意义(P<0.05)。临床疗效总有效率研究组94.44%,显著高于对照组81.48%,差异有统计学意义(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:舒肝解郁胶囊联合氟西汀治疗可在不增加不良反应的基础上显著降低抑郁程度,改善患者的睡眠质量及心率变异性。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shugan Jieyu capsules combined with fluoxetine for depression and its effect on heart rate variability. Methods: A total of 108 cases of patients with depression were selected as the study objects and divided into two groups according to the random number table method,54 cases in each group. The control group was treated with fluoxetine hydrochloride capsules,and the study group was additionally treated with Shugan Jieyu capsules based on the treatment of the control group. The Hamilton Depression Scale(HAMD), Hamilton Anxiety Scale(HAMA), Pittsburgh Sleep Quality Index(PSQI),the HRV indexes including standard deviation of the normal- to- normal sinus nodeinitiated R-R intervals(SDNN),Low Frequency(LF) and high frequency(HF),the clinical effect,and the incidence of adverse reactions in the two groups were compared. Results:After six-week treatment,the HAMD and PSQI in the two group were significantly lower than those before treatment,and the above indexes in the study group were all lower than those in the control group, differences being significant(P<0.05); HAMA in the two groups were lower than those before treatment, differences being significant(P<0.05), but there was no significant difference being found in the comparison of HAMA between the two groups(P>0.05). After six- week treatment, the levels of SDNN and HF in the study group were significantly higher than those before treatment, and those in the control group, the level of LF in the study group was significantly lower than those before treatment,and those in the control group,differences being significant(P<0.05). The total effective rate of clinical effect was 94.44% in the study group, significantly higher than that of 81.48% in the control group, the difference being significant(P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups(P>0.05). Conclusion: The treatment of fluoxetine combined with Shugan Jieyu capsules can significantly decrease depression degree and improve sleep quality and HRV without increasing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

王莹,李阳,吴云.舒肝解郁胶囊联合氟西汀治疗抑郁症临床疗效及对心率变异性的影响[J].新中医,2021,53(16):62-65

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-08-23
  • 出版日期: